Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Long-Term Deferred Tax: 2009-2024

Historic Long-Term Deferred Tax for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $458.4 million.

  • UNITED THERAPEUTICS's Long-Term Deferred Tax fell 9.21% to $354.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $354.9 million, marking a year-over-year decrease of 9.21%. This contributed to the annual value of $458.4 million for FY2024, which is 16.11% up from last year.
  • UNITED THERAPEUTICS's Long-Term Deferred Tax amounted to $458.4 million in FY2024, which was up 16.11% from $394.8 million recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's Long-Term Deferred Tax registered a high of $458.4 million during FY2024, and its lowest value of $238.6 million during FY2020.
  • Its 3-year average for Long-Term Deferred Tax is $393.6 million, with a median of $394.8 million in 2023.
  • Data for UNITED THERAPEUTICS's Long-Term Deferred Tax shows a peak YoY grew of 25.12% (in 2022) over the last 5 years.
  • Over the past 5 years, UNITED THERAPEUTICS's Long-Term Deferred Tax (Yearly) stood at $238.6 million in 2020, then grew by 9.77% to $261.9 million in 2021, then grew by 25.12% to $327.7 million in 2022, then climbed by 20.48% to $394.8 million in 2023, then climbed by 16.11% to $458.4 million in 2024.